MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Autonomic dysfunction"

  • 2019 International Congress

    Changes in Supine Blood Pressure with Long Term Use of Droxidopa

    S. Gorny, L. Hewitt, A. Lindsten, M. Karnik-Henry, S. Kymes, A. Favit (Deerfield, IL, USA)

    Objective: To determine the long-term effects of droxidopa use on supine blood pressure (BP) in patients with neurogenic orthostatic hypotension (nOH). Background: nOH is a…
  • 2019 International Congress

    The prevalence of supine hypertension and nocturnal hypertension and the difference of blood pressure in each sleep position in Parkinson’s disease

    J. Sringean, R. Hamindra, R. Bhidayasiri (Bangkok, Thailand)

    Objective: This study aimed to determine the prevalence, associated factors of SH/NH and to identify relationships between blood pressure (BP) and sleep position in PD…
  • 2019 International Congress

    Population Pharmacokinetics and Pharmacodynamics of Ampreloxetine (TD-9855) in Patients with Neurogenic Orthostatic Hypotension (nOH)

    A. Lo, J. Kanodia, R. Vickery, D. Bourdet (South San Francisco, CA, USA)

    Objective: To characterize the Phase 2 pharmacokinetics (PK) and pharmacodynamics (PD) of ampreloxetine in patients with nOH and provide dosing recommendations for special populations in…
  • 2019 International Congress

    Autonomic dysfunction in early Parkinson’s disease: a prospective study

    I. Stankovic, I. Petrovic, T. Pekmezovic, V. Markovic, T. Stojkovic, N. Dragasevic Miskovic, M. Svetel, V. Kostic (Belgrade, Serbia)

    Objective: To define prevalence, severity, and predictors of dysautonomia symptoms in patients with Parkinson's disease (PD) recruited at the Hoehn and Yahr stage 1 prospectively followed for three years.…
  • 2019 International Congress

    Differences in correlation with cardiac sympathetic denervation between depression and anhedonia in drug naïve Parkinson disease patients

    H. Murakami, T. Shiraishi, T. Umehara, S. Omoto, H. Motegi, R. Nakada, T. Sato, A. Onda, H. Matsuno, T. Komatsu, K. Bono, K. Sakai, H. Mitsumura, Y. Iguchi (Tokyo, Japan)

    Objective: To compare the correlation with some assessments of DAT scan and myocardial MIBG scintigraphy between depression and anhedonia in drug naive Parkinson's Disease (PD)…
  • 2019 International Congress

    Decreased baroreflex sensitivity in Parkinson’s disease is associated with orthostatic hypotension

    P. Turcani, P. Valkovic, P. Siarnik, S. Sutovsky (Bratislava, Slovakia)

    Objective: To compare the baroreflex sensitivity (BRS) of Parkinson’s disease patients with those of an age-matched control population, and to determine BRS association with blood pressure,…
  • 2019 International Congress

    Dry eye in Parkinson’s disease: symptoms, consequences and treatment options

    I. Csoti, N. Koleva-Alazeh (Leun, Germany)

    Objective: Dry eye is a common side effect of PD/PSP and easily manageable, yet its occurrence and debilitating ramifications are often unrecognized. The aim of…
  • 2019 International Congress

    Characteristics of lower gastrointestinal tract dysfunction in patients with Parkinson disease

    T. Uchiyama, T. Yamamoto, K. Suzuki, T. Kadowaki, H. Nakajima, R. Sakakibara, S. Kuwabara, K. Hirata, M. Murai (Chiba, Japan)

    Objective: To evaluate the characteristics of lower gastrointestinal tract dysfunction in patients with Parkinson disease (PD). Background: Lower gastrointestinal tract dysfunction is common in patients…
  • 2019 International Congress

    Abnormal respiratory rate and patterns in MSA

    E. Driver-Dunckley, B. Goodman (Scottsdale, AZ, USA)

    Objective: To evaluate respiratory rate and patterns in patients with Multiple Systems Atrophy (MSA). Background: One of the primary clinical features of multiple system atrophy…
  • 2019 International Congress

    Cardiovascular autonomic function and MCI in Parkinson’s disease

    CE. Cicero, L. Raciti, R. Monastero, G. Mostile, G. Donzuso, G. Sciacca, A. Luca, C. Terravecchia, L. Giuliano, R. Baschi, M. Davì, M. Zappia, A. Nicoletti (Catania, Italy)

    Objective: To evaluate the association between cardiovascular dysautonomia and Mild Cognitive Impairment (MCI) in Parkinson’s Disease (PD) patients. Background: Dysautonomic dysfunction and cognitive impairment represent…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 27
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley